BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11843384)

  • 21. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET.
    Zhang H; Tian M; Oriuchi N; Higuchi T; Tanada S; Endo K
    Br J Radiol; 2002 May; 75(893):409-16. PubMed ID: 12036833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lesion detectability and clinical effectiveness of dual-head coincidence gamma camera imaging in comparison with dedicated PET systems in tumour patients.
    Narin Y; Urhan M; Canpolat N; Vardereli E; Bayhan H
    J Int Med Res; 2007; 35(4):467-73. PubMed ID: 17697523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of lung cancer with positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
    Zhang H; Tian M; Oriuchi N; Higuchi T; Tanada S; Endo K
    Eur J Radiol; 2003 Sep; 47(3):199-205. PubMed ID: 12927663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.
    Andrieux A; Switsers O; Chajari MH; Jacob JH; Delozier T; Gervais R; Allouache N; Laurençon V; Henry-Amar M; Bardet S
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):68-77. PubMed ID: 16557206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
    Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-head gamma camera coincidence imaging in pancreatic cancer.
    Giorgi MC; Cunha RM; Soares J; Izaki M; Saito ET; de Barros Mott C; Cerri GG; Ramirez JA; Meneghetti JC
    Rev Esp Med Nucl; 2004; 23(2):90-4. PubMed ID: 15000938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras.
    Weber W; Young C; Abdel-Dayem HM; Sfakianakis G; Weir GJ; Swaney CM; Gates M; Stokkel MP; Parker A; Hines H; Khanvali B; Liebig JR; Leung AN; Sollitto R; Caputo G; Wagner HN
    J Nucl Med; 1999 Apr; 40(4):574-8. PubMed ID: 10210215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
    Stokkel MP; ten Broek FW; van Rijk PP
    Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection.
    Zimny M; Kaiser HJ; Cremerius U; Reinartz P; Schreckenberger M; Sabri O; Buell U
    Eur J Nucl Med; 1999 Aug; 26(8):818-23. PubMed ID: 10436193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma.
    Abdel-Dayem HM; Radin AI; Luo JQ; Marans HY; Wong S; Naddaf SY; El-Zeftawy HM; Omar WS; Mithilesh K; Abujudeh H; Atay S
    J Nucl Med; 1998 Apr; 39(4):654-6. PubMed ID: 9544675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
    Delbeke D; Martin WH; Patton JA; Sandler MP
    Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
    Gerbaudo VH; Sugarbaker DJ; Britz-Cunningham S; Di Carli MF; Mauceri C; Treves ST
    J Nucl Med; 2002 Sep; 43(9):1144-9. PubMed ID: 12215551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
    Pai M; Park CH; Suh JH; Koh JH
    Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
    Even-Sapir E; Yuzefovich B; Miller E; Bouhnik JP; Zak O; Lerman H; Lievshitz G; Levin C
    J Nucl Med Technol; 2004 Dec; 32(4):190-7. PubMed ID: 15576340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can pre-operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy?
    Byrom J; Widjaja E; Redman CW; Jones PW; Tebby S
    BJOG; 2002 Apr; 109(4):369-75. PubMed ID: 12013156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
    Tian M; Koyama K; Zhang H; Oriuchi N; Higuchi T; Endo K
    Nucl Med Commun; 2003 Apr; 24(4):367-74. PubMed ID: 12673164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coincidence camera FDG imaging for the diagnosis of chronic orthopedic infections: a feasibility study.
    de Winter F; Van de Wiele C; Vandenberghe S; de Bondt P; de Clercq D; D'Asseler Y; Dierckx R
    J Comput Assist Tomogr; 2001; 25(2):184-9. PubMed ID: 11242211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of spine metastases by FDG imaging using a gamma camera in the coincidence mode.
    Shreve PD; Steventon RS; Gross MD
    Clin Nucl Med; 1998 Dec; 23(12):799-802. PubMed ID: 9858288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
    Bhosale P; Peungjesada S; Wei W; Levenback CF; Schmeler K; Rohren E; Macapinlac HA; Iyer RB
    Int J Gynecol Cancer; 2010 Aug; 20(6):936-44. PubMed ID: 20683399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography.
    Peng NJ; Liou WS; Liu RS; Hu C; Tsay DG; Liu CB
    Cancer Biother Radiopharm; 2011 Apr; 26(2):175-81. PubMed ID: 21510748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.